{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:23:23Z","timestamp":1780773803240,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12350-019-01842-5","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T13:03:51Z","timestamp":1565615031000},"page":"1352-1364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients"],"prefix":"10.1016","volume":"27","clinical-trial-number":[{"clinical-trial-number":"nct00722631","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Nobuhiro","family":"Tahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehisa","family":"Bekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Maeda-Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Igata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-019-01842-5_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-019-01842-5_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-019-01842-5_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","article-title":"Hyperglycemia and cardiovascular disease in type 2 diabetes","volume":"48","author":"Laakso","year":"1999","journal-title":"Diabetes"},{"key":"10.1007\/s12350-019-01842-5_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2213-8587(18)30079-2","article-title":"Sex-specific relevance of diabetes to occlusive vascular and other mortality: A collaborative meta-analysis of individual data from 980793 adults from 68 prospective studies","volume":"6","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1007\/s12350-019-01842-5_bib5","unstructured":"Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet 1999;354:617-21."},{"key":"10.1007\/s12350-019-01842-5_bib6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1007\/s12350-019-01842-5_bib7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s001250050617","article-title":"Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up","volume":"39","author":"Hanefeld","year":"1996","journal-title":"Diabetologia"},{"key":"10.1007\/s12350-019-01842-5_bib8","article-title":"Insulin resistance the link between T2DM and CVD: Basic mechanisms and clinical implications","author":"Abdul-Ghani","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1007\/s12350-019-01842-5_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/157339907782330012","article-title":"Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: Effects on health of vascular tree","volume":"3","author":"Di Filippo","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"10.1007\/s12350-019-01842-5_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11883-013-0359-z","article-title":"Imaging atherosclerosis and risk of plaque rupture","volume":"15","author":"Osborn","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1007\/s12350-019-01842-5_bib11","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.ATV.0000131783.74034.97","article-title":"Morphologic findings of coronary atherosclerotic plaques in diabetics: A postmortem study","volume":"24","author":"Burke","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1007\/s12350-019-01842-5_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01842-5_bib13","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01842-5_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-019-01842-5_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tcm.2016.03.005","article-title":"Non-invasive and invasive imaging of vulnerable coronary plaque","volume":"26","author":"Celeng","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1007\/s12350-019-01842-5_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2018.03.001","article-title":"Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease","volume":"274","author":"Fujino","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1007\/s12350-019-01842-5_bib17","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"key":"10.1007\/s12350-019-01842-5_bib18","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01842-5_bib19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jacc.2006.03.069","article-title":"Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography","volume":"48","author":"Tahara","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01842-5_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: Implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01842-5_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jcmg.2011.08.007","article-title":"Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET\/CT imaging study of carotid artery and ascending aorta","volume":"4","author":"Mizoguchi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcmg.2010.01.004","article-title":"Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina","volume":"3","author":"Rogers","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jcmg.2013.09.004","article-title":"Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: Evaluation by FDG-PET\/CT imaging","volume":"6","author":"Nitta","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004195","article-title":"Coronary plaque morphology and the anti-inflammatory impact of atorvastatin: A multicenter 18F-fluorodeoxyglucose positron emission tomographic\/computed tomographic study","volume":"9","author":"Singh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib25","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/ATVBAHA.116.307293","article-title":"Vascular inflammation evaluated by [18F]-fluorodeoxyglucose-positron emission tomography\/computed tomography is associated with endothelial dysfunction","volume":"36","author":"Honda","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1007\/s12350-019-01842-5_bib26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.109.065151","article-title":"18F-FDG PET\/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease","volume":"50","author":"Rominger","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01842-5_bib27","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jcmg.2013.08.006","article-title":"Measurement of arterial activity on routine FDG PET\/CT images improves prediction of risk of future CV events","volume":"6","author":"Figueroa","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jcmg.2015.06.002","article-title":"Carotid FDG uptake improves prediction of future cardiovascular events in asymptomatic individuals","volume":"8","author":"Moon","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib29","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/jc.2005-2654","article-title":"Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome","volume":"91","author":"Yamagishi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s12350-019-01842-5_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/dmrr.820","article-title":"Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes","volume":"25","author":"Nakamura","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1007\/s12350-019-01842-5_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2008.11.169","article-title":"Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension","volume":"143","author":"Nakamura","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-019-01842-5_bib32","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1210\/jc.2010-0727","article-title":"Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: A 10-year prospective study","volume":"95","author":"Chen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s12350-019-01842-5_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/jc.2010-2140","article-title":"Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance","volume":"96","author":"Yang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s12350-019-01842-5_bib34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2174\/0929867324666170608103140","article-title":"Pigment epithelium-derived factor: A novel therapeutic target for cardiometabolic diseases and related complications","volume":"25","author":"Yamagishi","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1007\/s12350-019-01842-5_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.atherosclerosis.2011.06.022","article-title":"Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans","volume":"219","author":"Tahara","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1007\/s12350-019-01842-5_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijcard.2012.05.015","article-title":"Adiponectin is inversely associated with ratio of serum levels of AGEs to sRAGE and vascular inflammation","volume":"158","author":"Tahara","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-019-01842-5_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00259-015-3259-3","article-title":"Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis","volume":"43","author":"Bucerius","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib38","doi-asserted-by":"crossref","first-page":"E739","DOI":"10.1210\/jc.2014-3896","article-title":"Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET\/CT","volume":"100","author":"Tahara","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s12350-019-01842-5_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpendmet0366","article-title":"Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes","volume":"3","author":"Rask-Madsen","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1007\/s12350-019-01842-5_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.mayocp.2012.02.014","article-title":"Effect of insulin sensitizer therapy on atherothrombotic and inflammatory profiles associated with insulin resistance","volume":"87","author":"McCoy","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1007\/s12350-019-01842-5_bib41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1007\/s12350-019-01842-5_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MCA.0b013e3283519f25","article-title":"Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention","volume":"23","author":"Seo","year":"2012","journal-title":"Coron Artery Dis"},{"key":"10.1007\/s12350-019-01842-5_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-4835(91)90248-D","article-title":"PEDF: Pigment epithelium-derived factor with potent neuronal differentiative activity","volume":"53","author":"Tombran-Tink","year":"1991","journal-title":"Exp Eye Res"},{"key":"10.1007\/s12350-019-01842-5_bib44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrn1176","article-title":"PEDF: A multifaceted neurotrophic factor","volume":"4","author":"Tombran-Tink","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s12350-019-01842-5_bib45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ijo.2010.212","article-title":"Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells","volume":"35","author":"Famulla","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1007\/s12350-019-01842-5_bib46","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1210\/jc.2010-0630","article-title":"Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss","volume":"95","author":"Sabater","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1007\/s12350-019-01842-5_bib47","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1007\/s00592-012-0397-y","article-title":"Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients","volume":"49","author":"Gattu","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1007\/s12350-019-01842-5_bib48","doi-asserted-by":"crossref","first-page":"E2114","DOI":"10.1210\/jc.2012-1894","article-title":"Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people","volume":"97","author":"Sunderland","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s12350-019-01842-5_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00259-013-2569-6","article-title":"Optimizing 18F-FDG PET\/CT imaging of vessel wall inflammation: The impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels","volume":"41","author":"Bucerius","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01842-5_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00006231-200110000-00011","article-title":"Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?","volume":"22","author":"Zhuang","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-019-01842-5_bib51","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2967\/jnumed.109.074294","article-title":"Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET\/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis","volume":"51","author":"Rabkin","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-019-01842-5_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nm.3437","article-title":"2-Deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis","volume":"20","author":"Tahara","year":"2014","journal-title":"Nat Med"},{"key":"10.1007\/s12350-019-01842-5_bib53","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01842-5_bib54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): A randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-019-01842-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123019542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123019542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:50Z","timestamp":1761026870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123019542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1071358123019542"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01842-5","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01842-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}